| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mark B Detweiler, Kelly Sullivan, Taral R Sharma, Kye Y Kim, Jonna G Detweile. Case reports of neuroleptic malignant syndrome in context of quetiapine use. The Psychiatric quarterly. vol 84. issue 4. 2014-06-09. PMID:23686527. |
a retrospective analysis was followed on 20 case reports covering the possible correlation between the atypical antipsychotic, quetiapine, and neuroleptic malignant syndrome (nms), determined by the study of 7 different nms criteria guidelines. |
2014-06-09 |
2023-08-12 |
Not clear |
| Mark B Detweiler, Kelly Sullivan, Taral R Sharma, Kye Y Kim, Jonna G Detweile. Case reports of neuroleptic malignant syndrome in context of quetiapine use. The Psychiatric quarterly. vol 84. issue 4. 2014-06-09. PMID:23686527. |
only one case was found to have no other medication or medical conditions confounding the relationship of quetiapine and nms symptoms, and that case was in the context of a significant quetiapine overdose. |
2014-06-09 |
2023-08-12 |
Not clear |
| Mark B Detweiler, Kelly Sullivan, Taral R Sharma, Kye Y Kim, Jonna G Detweile. Case reports of neuroleptic malignant syndrome in context of quetiapine use. The Psychiatric quarterly. vol 84. issue 4. 2014-06-09. PMID:23686527. |
nor was quetiapine proven to be the sole cause of the possible nms in the two age groups investigated. |
2014-06-09 |
2023-08-12 |
Not clear |
| Steven C Stoner, Amy Berr. Suspected neuroleptic malignant syndrome during quetiapine-clozapine cross-titration. Journal of pharmacy practice. vol 23. issue 1. 2012-03-22. PMID:21507795. |
in this case, we present a patient who developed symptoms of nms during the cross-taper and conversion from quetiapine to clozapine. |
2012-03-22 |
2023-08-12 |
Not clear |
| Timothy C Randolp. Possible contribution of XYY syndrome to neuroleptic malignant syndrome in a child receiving quetiapine. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. vol 67. issue 6. 2010-06-09. PMID:20208052. |
a case of early neuroleptic malignant syndrome (nms) in a child with xyy syndrome after three weeks of quetiapine therapy is reported. |
2010-06-09 |
2023-08-12 |
Not clear |
| Justine Schuller Gortney, Alexandria Fagan, Julie Cold Kissac. Neuroleptic malignant syndrome secondary to quetiapine. The Annals of pharmacotherapy. vol 43. issue 4. 2010-01-04. PMID:19299325. |
to report a case of neuroleptic malignant syndrome (nms) secondary to quetiapine in which the patient developed extrapyramidal symptoms (eps). |
2010-01-04 |
2023-08-12 |
Not clear |
| Julian N Trollor, Xiaohua Chen, Perminder S Sachde. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS drugs. vol 23. issue 6. 2009-08-18. PMID:19480467. |
we used medline and embase to identify nms case reports and systematic reviews published to june 2008 related to the atypical antipsychotic drugs clozapine, olanzapine, risperidone, paliperidone, aripiprazole, ziprasidone, amisulpride and quetiapine. |
2009-08-18 |
2023-08-12 |
Not clear |
| Paul E Croarkin, Graham J Emslie, Taryn L Maye. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. The Journal of clinical psychiatry. vol 69. issue 7. 2008-09-09. PMID:18572981. |
to retrospectively examine published cases of neuroleptic malignant syndrome (nms) in patients aged 18 and below who had been treated with atypical antipsychotics (clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole). |
2008-09-09 |
2023-08-12 |
Not clear |
| Biswaranjan Mishra, Baikunthanath Mishra, Saddichha Sahoo, Manu Arora, C R J Khes. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine. Indian journal of medical sciences. vol 61. issue 10. 2008-05-14. PMID:17932448. |
however, nms cases have been reported with risperidone, clozapine, olanzapine and quetiapine. |
2008-05-14 |
2023-08-12 |
Not clear |
| Akiko Kobayashi, Chiaki Kawanishi, Takehiko Matsumura, Daiji Kato, Ryoko Furukawa, Ikuko Kishida, Yoshio Hirayas. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 6. 2006-08-23. PMID:16682107. |
the present report is the first to describe a dlb patient who developed neuroleptic malignant syndrome (nms) induced by quetiapine, an atypical neuroleptic known to have relatively infrequent extrapyramidal side effects in dlb patients. |
2006-08-23 |
2023-08-12 |
Not clear |
| Dong-Seon Chungh, Boong-Nyun Kim, Soo-Churl Ch. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child. Journal of psychopharmacology (Oxford, England). vol 19. issue 4. 2005-09-08. PMID:15982999. |
this article discusses the first case of nms in a child, induced by the use of risperidone, olanzapine and quetiapine. |
2005-09-08 |
2023-08-12 |
Not clear |
| Debra K Farve. Neuroleptic malignant syndrome induced by atypical antipsychotics. Expert opinion on drug safety. vol 2. issue 1. 2003-09-12. PMID:12904122. |
case reports have also been published concerning nms and clozapine, risperidone, olanzapine and quetiapine. |
2003-09-12 |
2023-08-12 |
Not clear |
| C D Hatch, B C Lund, P J Perr. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics. Pharmacotherapy. vol 21. issue 8. 2002-05-17. PMID:11718487. |
a 54-year-old man was unsuccessfully challenged with quetiapine after conventional antipsychotic-induced nms. |
2002-05-17 |
2023-08-12 |
Not clear |